title: Infliximab and the bone in Crohn's disease.
authors.forename: R
authors.initials: R
authors.lastname: Kunisaki
authors.forename: O
authors.initials: O
authors.lastname: Chaki
authors.forename: T
authors.initials: T
authors.lastname: Taguchi
authors.forename: T
authors.initials: T
authors.lastname: Sugiyama
authors.forename: A
authors.initials: A
authors.lastname: Sugita
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects*; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008297:Male; D010012:Osteogenesis / Q000187:drug effects*
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab